Page 52 - 15DEC2019E-5
P. 52

New AIDS drug to                                                      The Ministry of Health


                                                                                seeks to make the country
                  be available by                                               HIV/AIDS free by 2030
                                                                                with stress on zero
                                                                                infections by then. And the
                    February 2020                                               new Dolutegravir drug is
                                                                                a step in right direction,

                                                                                reports tehelka bureau

                 he Union Health Ministry   Health Minister Harsh Vardhan said.
                 has planned to introduce a   As of now the current estimates of
                 new drug for the treatment   People Living with HIV (PLHIV) is about
                 of patients suffering from   2.14 million, said the official. The health
         T HIV/AIDS. “Dolutegravir” is    ministry has set the target to achieve
         a new drug which is likely to be avail-  the target of Sustainable Development
         able in the market by February 2020. Dr   Goal (SDG) by eliminating the epidemic
         Naresh Goel, Deputy Director-General   of HIV/AIDS from India by 2030.
         of National AIDS Control Organization   According to Union Health Minis-
         (NACO) said in an interview: “Previ-  ter Dr Harsh Vardhan, “During 2018-19,
         ously, we have been using the combi-  about 79 per cent people living with
         nation drug of TLE. But now, the health   HIV knew their status and 82 per cent
         ministry has decided to use TLD com-  diagnosed with HIV are receiving free
         bination drug - known as Dolutegravir.   antiretroviral therapy and 79 per cent
         It has fewer side effects and tolerance   are virally suppressed. The basic tar-
         is better.”                      get remains that of ‘’Three Zeros’’ — i.e.
           Informing about the other advan-  zero new infections, zero AIDS-related
         tages of Dolutegravir drug, the official   deaths and zero discrimination.”
         said that the resistance to the new   As per the official data by NACO, eve-
         drug will develop late and adherence   ry year about 88,000 new infections are
         is better. “The viral suppression is faster   added to their list. NACO has strength-
         with the use of this new drug. We have   ened its monitoring mechanism with
         started training our doctors on how to   more than 35,000 reporting units
         prescribe the new drug to the patients.   providing information on completely
         By January, it will be done and in Febru-  IT-enabled system. Since 1980s NACO
         ary, we will launch the drug,” he added.  is playing a key role in fighting against
           Nearly eight in every 10 persons   the disease and reducing the preva-  In real terms, there has been a rise in
         living with HIV are under treatment,    lence of HIV/AIDS in the country. It has   AIDS-related deaths between 2015 and
         according to the government data, and   signed MOU with 18 Central govern-  2017 with 69,110 dying of the infection
         efforts are underway to expand the   ment ministries to combat the disease.   in 2017 as against 67,612 two years ago.
         coverage basket. The Ministry of Health   Treatment access remains a chal-  The number of people living with
         recently reiterated its resolve to make   lenge with most patients finding it dif-  the infection has risen from 21.17 lakh in
         India HIV/AIDS free by 2030 with stress   ficult to use anti-retro viral dispensing   2015 to 21.40 lakh now. HIV prevalence
         on zero infections by then.      facilities. Treatment gap remains the   in adults has declined over the years
           The National  AIDS Control Or-  big challenge for HIV control.  and is now 0.22 per cent as against
         ganisation statistics for 2017-2018   The ambitious goal of ending HIV   0.28 per cent in 2015. Experts working
         show 79 per cent people living with   by 2030 notwithstanding, as per the   in the HIV sector say new infections
         HIV know their status which makes it   latest HIV estimates published by the    remain a challenge with 40 per cent
         easier to seek treatment. “Post treat-  National Aids Control Organisation,   being reported among women.  As
         ment, around 79 per cent people have   India has  reported only marginal    of 2015, there were 89,000 new HIV
         their viral load suppressed. We are on   improvements in the fight against   infections in India. This has marginally
         the right track to ridding India of HIV,”   the epidemic between 2015 and now.   reduced to 87,000, showing the slow


                                                        52
   47   48   49   50   51   52   53   54   55   56   57